↓ Skip to main content

Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study

Overview of attention for article published in Frontiers in oncology, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study
Published in
Frontiers in oncology, September 2022
DOI 10.3389/fonc.2022.945123
Pubmed ID
Authors

Xiaobo Zhang, Xiao Zhang, Xiaoyi Ding, Zhongmin Wang, Yong Fan, Guang Chen, Xiaokun Hu, Jiasheng Zheng, Zhixiao Xue, Xiaofeng He, Xin Zhang, Yingtian Wei, Zhongliang Zhang, Jing Li, Jie Li, Jie Yang, Xiaodong Xue, Li Ma, Yueyong Xiao

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 18%
Student > Bachelor 1 9%
Student > Master 1 9%
Unknown 7 64%
Readers by discipline Count As %
Medicine and Dentistry 2 18%
Business, Management and Accounting 1 9%
Environmental Science 1 9%
Unknown 7 64%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2022.
All research outputs
#16,905,919
of 25,830,657 outputs
Outputs from Frontiers in oncology
#6,601
of 22,811 outputs
Outputs of similar age
#236,082
of 439,159 outputs
Outputs of similar age from Frontiers in oncology
#536
of 1,735 outputs
Altmetric has tracked 25,830,657 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,811 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,159 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,735 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.